Established Tirzepatide stacks
Lean-Mass Preservation
Goal: Offset lean-mass loss during caloric deficit
Researchers studying GLP-1-driven weight loss often pair GH secretagogues to model lean-mass preservation. This is not a clinical protocol.
How to think about stacking
- Mechanism diversity beats redundancy. Pairing compounds that hit different pathways usually outperforms stacking two compounds with similar mechanisms.
- Track one variable at a time. Starting two peptides simultaneously makes it impossible to attribute effects. Research protocols typically introduce stacks sequentially.
- Side-effect interactions. Some peptides compound each other's side effects (e.g., GLP-1 agonists with other GI-active compounds). Review side-effect profiles before stacking.